technology

Insilico Partners with US Firm to Develop AI Model for Human Longevity

26 Mayıs 2026Bllomberg

Insilico Medicine Cayman TopCo, a Hong Kong-based AI drug discovery firm, is collaborating with a U.S. partner to develop an artificial intelligence model aimed at enhancing human longevity.
This initiative signifies a growing trend in leveraging AI for biomedical advancements, particularly in the field of aging and healthspan extension. The partnership reflects the increasing recognition of AI's potential to revolutionize healthcare and improve life expectancy.
The pursuit of extending human life through technological means is gaining traction globally, with various firms exploring innovative solutions. Insilico's focus on AI in drug discovery aligns with broader trends in the biotech industry, where computational methods are increasingly utilized to accelerate research an…
The collaboration between Insilico and a U.S. partner underscores a pivotal shift in the biomedical landscape, where AI is no longer just a tool but a key player in addressing complex health challenges.

NewsAI özeti

This article reflects the views of the source and does not necessarily represent the views of the newsroom.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.